Cetera Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $6.66M | Buy |
98,262
+54,488
| +124% | +$3.69M | 0.05% | 363 |
|
|
2023
Q4 | $2.95M | Buy |
43,774
+23,756
| +119% | +$1.6M | 0.04% | 397 |
|
|
2023
Q3 | $1.36M | Buy |
20,018
+405
| +2% | +$27.4K | 0.02% | 609 |
|
|
2023
Q2 | $1.4M | Sell |
19,613
-5,532
| -22% | -$396K | 0.02% | 597 |
|
|
2023
Q1 | $1.75M | Buy |
25,145
+44
| +0.2% | +$3.05K | 0.03% | 496 |
|
|
2022
Q4 | $1.7M | Sell |
25,101
-4,943
| -16% | -$335K | 0.03% | 496 |
|
|
2022
Q3 | $2K | Buy |
30,044
+15,907
| +113% | +$1.06K | ﹤0.01% | 1294 |
|
|
2022
Q2 | $934K | Sell |
14,137
-493
| -3% | -$32.6K | 0.02% | 595 |
|
|
2022
Q1 | $971K | Buy |
14,630
+66
| +0.5% | +$4.38K | 0.02% | 623 |
|
|
2021
Q4 | $848K | Sell |
14,564
-5,393
| -27% | -$314K | 0.02% | 667 |
|
|
2021
Q3 | $1.2M | Buy |
19,957
+3,452
| +21% | +$207K | 0.02% | 548 |
|
|
2021
Q2 | $989K | Buy |
16,505
+6,819
| +70% | +$409K | 0.02% | 553 |
|
|
2021
Q1 | $482K | Sell |
9,686
-352
| -4% | -$17.5K | 0.01% | 760 |
|
|
2020
Q4 | $502K | Buy |
10,038
+422
| +4% | +$21.1K | 0.02% | 639 |
|
|
2020
Q3 | $527K | Buy |
9,616
+784
| +9% | +$43K | 0.02% | 537 |
|
|
2020
Q2 | $467K | Sell |
8,832
-11,250
| -56% | -$595K | 0.02% | 553 |
|
|
2020
Q1 | $897K | Buy |
20,082
+1,724
| +9% | +$77K | 0.05% | 341 |
|
|
2019
Q4 | $919K | Sell |
18,358
-296
| -2% | -$14.8K | 0.04% | 389 |
|
|
2019
Q3 | $827K | Sell |
18,654
-664
| -3% | -$29.4K | 0.04% | 403 |
|
|
2019
Q2 | $795K | Buy |
19,318
+1,865
| +11% | +$76.8K | 0.04% | 442 |
|
|
2019
Q1 | $706K | Buy |
17,453
+8,528
| +96% | +$345K | 0.04% | 403 |
|
|
2018
Q4 | $339K | Buy |
+8,925
| New | +$339K | 0.02% | 597 |
|